An in vitro study showed that B cells suppress tumor immunity by downregulating the expression of IFN-γ in CD8+ T cells, a cytokine possessing antitumor activity [188], while increasing interleukin-10 (IL-10) production that further inhibits IFN-γ production by T cells [189]. Here, CD8A is linked to neoplasm.